Literature DB >> 17053782

C-terminal phosphorylation controls the stability and function of p27kip1.

Uta Kossatz1, Jörg Vervoorts, Irina Nickeleit, Holly A Sundberg, J Simon C Arthur, Michael P Manns, Nisar P Malek.   

Abstract

Entry of cells into the cell division cycle requires the coordinated activation of cyclin-dependent kinases (cdks) and the deactivation of cyclin kinase inhibitors. Degradation of p27kip1 is known to be a central component of this process as it allows controlled activation of cdk2-associated kinase activity. Turnover of p27 at the G1/S transition is regulated through phosphorylation at T187 and subsequent SCF(skp2)-dependent ubiquitylation. However, detailed analysis of this process revealed the existence of additional pathways that regulate the abundance of the protein in early G1 and as cells exit quiescence. Here, we report on a molecular mechanism that regulates p27 stability by phosphorylation at T198. Phosphorylation of p27 at T198 prevents ubiquitin-dependent degradation of free p27. T198 phosphorylation also controls progression through the G1 phase of the cell cycle by regulating the association of p27 with cyclin-cdk complexes. Our results unveil the molecular composition of a pathway, which regulates the abundance and activity of p27kip1 during early G1. They also explain how the T187- and the T198-dependent turnover systems synergize to allow cell cycle progression in G1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053782      PMCID: PMC1630410          DOI: 10.1038/sj.emboj.7601388

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability.

Authors:  N Ishida; M Kitagawa; S Hatakeyama; K Nakayama
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

2.  p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.

Authors:  H Sutterlüty; E Chatelain; A Marti; C Wirbelauer; M Senften; U Müller; W Krek
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

3.  p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells.

Authors:  S K Kolluri; C Weiss; A Koff; M Göttlicher
Journal:  Genes Dev       Date:  1999-07-01       Impact factor: 11.361

4.  p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis.

Authors:  G Rodier; A Montagnoli; L Di Marcotullio; P Coulombe; G F Draetta; M Pagano; S Meloche
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication.

Authors:  K Nakayama; H Nagahama; Y A Minamishima; M Matsumoto; I Nakamichi; K Kitagawa; M Shirane; R Tsunematsu; T Tsukiyama; N Ishida; M Kitagawa; K Nakayama; S Hatakeyama
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

6.  A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase.

Authors:  N P Malek; H Sundberg; S McGrew; K Nakayama; T R Kyriakides; J M Roberts; T R Kyriakidis
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

7.  Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization.

Authors:  Naoya Fujita; Saori Sato; Kazuhiro Katayama; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

8.  Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest.

Authors:  Sandra Ciarallo; Venkateswaran Subramaniam; Wesley Hung; Jin-Hwa Lee; Rouslan Kotchetkov; Charanjit Sandhu; Andrea Milic; Joyce M Slingerland
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

9.  Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.

Authors:  Giuseppe Viglietto; Maria Letizia Motti; Paola Bruni; Rosa Marina Melillo; Amelia D'Alessio; Daniela Califano; Floriana Vinci; Gennaro Chiappetta; Philip Tsichlis; Alfonso Bellacosa; Alfredo Fusco; Massimo Santoro
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

10.  A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.

Authors:  Manfred Boehm; Takanobu Yoshimoto; Martin F Crook; Shriram Nallamshetty; Andrea True; Gary J Nabel; Elizabeth G Nabel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

View more
  43 in total

1.  Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.

Authors:  Chiara Bardella; Martina Olivero; Annalisa Lorenzato; Massimo Geuna; Julie Adam; Linda O'Flaherty; Pierre Rustin; Ian Tomlinson; Patrick J Pollard; Maria Flavia Di Renzo
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 2.  Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy.

Authors:  Seth A Wander; Bryan T Hennessy; Joyce M Slingerland
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

3.  RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.

Authors:  Michelle D Larrea; Feng Hong; Seth A Wander; Thiago G da Silva; David Helfman; Deborah Lannigan; Jeffrey A Smith; Joyce M Slingerland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-22       Impact factor: 11.205

4.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

5.  Siah1/SIP regulates p27(kip1) stability and cell migration under metabolic stress.

Authors:  Yoshito Nagano; Toru Fukushima; Kazuo Okemoto; Keiichiro Tanaka; David D L Bowtell; Ze'ev Ronai; John C Reed; Shu-ichi Matsuzawa
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

6.  Regulation of p27Kip1 phosphorylation and G1 cell cycle progression by protein phosphatase PPM1G.

Authors:  Chuang Sun; Gaohang Wang; Katharine H Wrighton; Han Lin; Zhou Songyang; Xin-Hua Feng; Xia Lin
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

7.  Characterization of a naturally-occurring p27 mutation predisposing to multiple endocrine tumors.

Authors:  Sara Molatore; Eva Kiermaier; Christian B Jung; Misu Lee; Elke Pulz; Heinz Höfler; Michael J Atkinson; Natalia S Pellegata
Journal:  Mol Cancer       Date:  2010-05-21       Impact factor: 27.401

8.  Impact of siRNA targeting pirh2 on proliferation and cell cycle control of the lung adenocarcinoma cell line A549.

Authors:  Yuan Su; Liping Zhu; Yang Jin; Xiaoju Zhang; Qiong Zhou; Ming Bai
Journal:  Front Med China       Date:  2007-10-01

9.  Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.

Authors:  Dana-Lynn T Koomoa; Lisette P Yco; Tamas Borsics; Christopher J Wallick; André S Bachmann
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis.

Authors:  Valerie A Trabosh; Kyle A Divito; Baltazar D Aguda; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Carcinogenesis       Date:  2009-05-18       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.